Qatar Neurology Devices Market Analysis Report 2022 to 2030

Qatar Neurology Devices Market Analysis

$ 3999

Qatar Neurology Devices Market size was valued at $50 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Mn in 2030. The Qatar Neurology devices market is expected to increase due to the country's ageing population. The prevalence of neurological conditions in the elderly, including stroke, dementia, and Parkinson's disease, will drive up demand for neurology devices. The market is segmented by product type and by the end user. Some key players in this market include Tech Q, Al-Sahel Medical, Medtronic, Johnson and Johnson, Boston Scientific, Stryker and GE Healthcare.

ID: IN10QAMD012 CATEGORY: Medical Devices GEOGRAPHY: Qatar AUTHOR: Jigyasu Bhandari

Buy Now

Qatar Neurology Devices Market Executive Analysis

Qatar Neurology Devices Market is at around $50 Mn in 2022 and is projected to reach $xx Mn in 2030, exhibiting a CAGR of xx % during the forecast period. It is anticipated that private health spending, which made up 25% of all health spending in Qatar in 2020, will represent 32% of all health spending by 2025 and 37% by 2030. Qatar forecasts that overall healthcare spending would rise from $5.5 Bn in 2020 to $6.8 Bn by 2025. Qatar has a higher incidence of stroke than the rest of the world, at 130.6 per 100,000 person-years. In Qatar, there were 189.5 cases of Parkinson's disease per 100,000 people.

In order to better understand the origins and mechanisms of neurological illnesses and to create innovative treatments, neurology devices are utilized in research. Transcranial Magnetic Stimulation (TMS) devices, for instance, can be used to activate various brain regions and examine how this affects neurological function. Many neurological problems can be treated with the aid of neurology devices. By sending electrical impulses to particular parts of the brain, Deep Brain Stimulation (DBS) devices, for instance, are used to treat movement disorders including Parkinson's disease and essential tremors. Neurology devices can be used to track the development of neurological illnesses and the efficacy of therapies. Electroencephalography equipment, for instance, can be used to track irregularities in people with epilepsy who have aberrant brain activity.

Qatar Neurology Device Market Analysis

Market Dynamics

Market Growth Drivers

The Qatar Neurology devices market is expected to increase due to the country's ageing population. The prevalence of neurological conditions in the elderly, including stroke, dementia, and Parkinson's disease, will drive up demand for neurology devices. Manufacturers may now create more sophisticated and efficient devices that can diagnose and treat neurological problems because of advancements in neurology device technology. This will probably result in a rise in demand for these devices in Qatar. The prevalence of neurological illnesses is rising in Qatar as a result of a number of causes, including age, stress, and alterations in our way of life. This will probably increase the demand for neurology devices in Qatar.

Market Restraints

In Qatar, the regulations governing neurology devices can be stringent and complicated. It could be difficult for manufacturers to get the certificates and approvals they need to sell their devices in the country. The most recent innovations in neurology devices and their uses may not be known to patients and healthcare providers. This may reduce the market's expansion and the demand for these products.

Competitive Landscape

Key Players

Techno Q (QA)
Al-Sahel Medical (QA)
Medtronic
Boston Scientific
Stryker
Johnson and Johnson

Notable Deals

2022: A distribution agreement between San Diego-based BrainScope and Neurotechnology Qatar was signed in 2022. According to the contract, Neurotechnology Qatar is permitted to provide cutting-edge EEG technology in Middle Eastern countries.

2021: Nihon Kohden, a global distributor of medical devices, and Techno Q joined forces in 2021. According to the contract, Techno Q was designated as Nihon Kohden's sole distributor for EEG and EMG devices in Qatar.

Healthcare Policies and Regulatory Landscape

The Supreme Council of Health (SCH), which is in charge of creating national healthcare policy and regulating the provision of healthcare services, oversees the regulation of the healthcare sector in Qatar. In order to ensure that neurology devices are high-quality, safe, and effective, the SCH also regulates them. The Medical Devices and Technologies Division (MDTD) of the SCH oversees the regulatory environment for neurology devices in Qatar. The MDTD is in charge of overseeing the nation's registration, importation, and distribution of neurology devices. Manufacturers who wish to sell neurology devices in Qatar must submit an application to the MDTD and give proof of the device's security and efficiency.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Neurology Device Market Segmentation

The Neurology Device Market is segmented as mentioned below:

By Product Type (Revenue, USD Billion):

Neurostimulation
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation
Vagus Nerve Stimulation
Gastric Electric Stimulation
Interventional Neurology
- Aneurysm Coiling & Embolization
- Embolic Coils
- Flow Diversion Devices
- Liquid Embolic Agents
- Cerebral Balloon Angioplasty & Stenting
- Carotid Artery Stents
- Filter Devices
- Balloon Occlusion Devices
- Neurothrombectomy
- Clot Retriever
- Suction Aspiration Devices
- Snares
CSF Management
- CSF Shunts
- CSF Drainage
Neurosurgery Devices
- Ultrasonic Aspirators
- Stereotactic Systems
- Neuroendoscopes
- Aneurysm Clips

By End User (Revenue, USD Billion):

Hospitals and Clinics
Specialty Centres
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.